Longevity Health Holdings, Inc. (XAGE)
0.111
0.00 (0.00%)
USD |
OTCM |
Nov 02, 16:00
Longevity Health Holdings Enterprise Value : 0.5612M for Nov. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 0.5612M |
| October 30, 2026 | 0.5614M |
| October 29, 2026 | 0.5614M |
| October 28, 2026 | 0.5614M |
| October 27, 2026 | 0.5614M |
| October 26, 2026 | 0.5636M |
| October 23, 2026 | 0.5636M |
| October 22, 2026 | 0.5636M |
| October 21, 2026 | 0.5636M |
| October 20, 2026 | 0.5636M |
| October 19, 2026 | 0.5636M |
| October 16, 2026 | 0.5636M |
| October 15, 2026 | 0.5636M |
| October 14, 2026 | 0.5636M |
| October 13, 2026 | 0.5636M |
| October 12, 2026 | 0.5612M |
| October 09, 2026 | 0.5612M |
| October 08, 2026 | 0.5841M |
| October 07, 2026 | 0.5841M |
| October 06, 2026 | 0.5841M |
| October 05, 2026 | 0.5841M |
| October 02, 2026 | 0.5921M |
| October 01, 2026 | 0.6265M |
| September 30, 2026 | 0.6646M |
| September 29, 2026 | 0.6728M |
| Date | Value |
|---|---|
| September 28, 2026 | 0.6728M |
| September 25, 2026 | 0.6728M |
| September 24, 2026 | 0.6725M |
| September 23, 2026 | 0.6725M |
| September 22, 2026 | 0.6725M |
| September 21, 2026 | 0.7072M |
| September 18, 2026 | 0.7072M |
| September 17, 2026 | 0.7072M |
| September 16, 2026 | 0.707M |
| September 15, 2026 | 0.707M |
| September 14, 2026 | 0.707M |
| September 11, 2026 | 0.707M |
| September 10, 2026 | 0.754M |
| September 09, 2026 | 0.754M |
| September 08, 2026 | 0.8062M |
| September 04, 2026 | 0.8062M |
| September 03, 2026 | 0.8384M |
| September 02, 2026 | 0.8384M |
| September 01, 2026 | 0.8384M |
| August 31, 2026 | 0.8384M |
| August 28, 2026 | 0.8384M |
| August 27, 2026 | 0.8384M |
| August 26, 2026 | 0.9711M |
| August 25, 2026 | 0.9711M |
| August 24, 2026 | 0.9711M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 246.60M |
| Perspective Therapeutics, Inc. | -114.26M |
| Achieve Life Sciences, Inc. | 506.61M |
| MiMedx Group, Inc. | 357.84M |
| ProText Mobility, Inc. | 67.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.883M |
| Revenue (Quarterly) | 0.396M |
| Total Expenses (Quarterly) | 2.279M |
| EPS Diluted (Quarterly) | -0.7608 |
| Gross Profit Margin (Quarterly) | 50.38% |
| Profit Margin (Quarterly) | -475.6% |
| Earnings Yield | -3.17K% |
| Normalized Earnings Yield | -2976.49 |